Background The usefulness of lower urinary tract symptoms (LUTS) as mortality risk factors remains unclear. Repeated assessments are required to take into account symptom fluctuation and de novo symptom appearance. The study objective was to evaluate mortality in relation to three urinary storage symptoms-urgency, daytime frequency, and nocturia-in middle-aged and elderly men, considering also other time-varying factors during follow-up. Methods A mail survey of a population-based cohort of men initially aged 50, 60, and 70 years was conducted in Finland in 1994Finland in , 1999Finland in , 2004Finland in , and 2009. The questionnaire included assessments of LUTS based on the Danish Prostatic Symptom Score and comorbidities. The men were followed up for mortality through the population registry through 2014. LUTSrelated hazard ratios (HR) were analyzed with time-dependent Cox regression adjusted for the year of birth and comorbidities using variable values updated every 5 years. Sensitivity analyses were conducted using values of all variables fixed to the baseline assessment of 1994. Results Of the 1332 eligible men with data on LUTS from each preceding survey, 514 (38.6%) died during the 21-year follow-up. In time-dependent analyses, daytime frequency, and nocturia were significantly associated with increased mortality: the adjusted HR was 1.42 (95% CI 1.11-1.83) for daytime frequency, 1.38 (1.07-1.79) for nocturia and 1.19 (0.94-1.50) for urgency. In sensitivity analyses with fixed baseline characteristics, only nocturia was suggestively associated with an increased risk of death: the adjusted HR was 1.09 (0.84-1.42) for daytime frequency, 1.41 (0.99-2.02) for nocturia and 0.94 (0.52-1.68) for urgency. Conclusions Among aging men, LUTS are more accurate predictors of short-term than longer-term mortality risk. Repeated assessments are needed to detect clinically relevant and persistent symptoms, often associated with ill health. Accordingly, men with daytime frequency or nocturia exhibit a 1.4-fold risk of death and therefore, should be evaluated for underlying comorbidity.
Introduction
The number of patients presenting with lower urinary tract symptoms (LUTS) is increasing as the population ages. LUTS are divided into two broad categories: storage symptoms (daytime urinary frequency, nocturia, urgency, urinary incontinence) and voiding symptoms (incomplete emptying, intermittency, slow stream, and hesitancy). An important factor for male LUTS is bladder outlet obstruction (BOO), typically caused by benign prostatic hyperplasia (BPH)-a condition affecting more than half of men aged over 50 years [1] . Although various interventions can alleviate bothersome LUTS, persistent or recurrent symptoms are frequent despite treatments such as surgery for BOO [2, 3] . This is explained by the multifactorial etiology of LUTS: age-related physiological changes, various lifestyle factors and medical conditions affect lower urinary tract and renal function. Of the various LUTS, comorbidities are particularly important for urinary storage symptoms [4, 5] .
As men with LUTS tend to be older and are more likely to have comorbidities than asymptomatic men, they are potentially at a higher risk of death. To reliably assess the impact of LUTS on mortality, careful consideration of various confounding factors is warranted. Longitudinal studies have suggested LUTS to predict development of cardiovascular diseases, albeit with some inconsistency [6, 7] . In previous longitudinal studies, LUTS have commonly been assessed either by using pre-defined cutoff values of various symptom scores or by retrospectively screening medical records for diagnosis codes without distinguishing individual symptoms. In the case of nocturia-the only symptom for which an association with mortality has been addressed in several earlier studies-the heterogeneity among previous results may reflect variation in methods, follow-up times and age distributions [8] , as the natural course of LUTS may vary considerably between populations [9] [10] [11] . Hypothetically, the confidence of the estimates on LUTS-related mortality could be strengthened by taking into account the incidence and remission of symptoms and comorbidities in the course of follow-up. Therefore, the aim of this study is to analyze the impact of three common storage LUTS-urinary urgency, daytime frequency, and nocturia-on all-cause mortality during 21 years of follow-up utilizing repeated assessments in a population-based cohort of middle-aged and elderly men.
Subjects and methods
Tampere aging male urologic study A population-based cohort study focusing on urological symptoms and sexual functioning among middle-aged and elderly men was launched in Pirkanmaa County, Finland in 1994, with repeat rounds in 1999, 2004, and 2009. Study details have been published previously [12, 13] . Briefly, a sample of 3143 men was identified from the Finnish Population Register in 1994, comprising all men born in 1924, 1934, or 1944 residing in the study area at the baseline. Self-administered questionnaires were mailed to the men in the study population at all rounds. Nonresponders were reminded with a second mailing after 3 months. The questionnaire comprised items on frequency and bother of LUTS, major health conditions and medications, as well as sociodemographic, anthropometric, and lifestyle factors. An exemption from ethical review was granted by the ethics committee of the Pirkanmaa Hospital District (tracking number 99050).
Measures
The frequencies of LUTS were assessed using the Danish Prostatic Symptom Score (DAN-PSS-1) [14] , consistent with the International Continence Society definitions [15] . An exception was made in 1994 in the assessment of urgency, where a modified question translated back from Finnish to English was as follows: "Is your need to urinate so urgent that it is difficult to hold it back until you reach the toilet?", which was since modified and used at subsequent the rounds in 1999, 2004, and 2009 as "Do you experience an imperative (strong) urge to urinate?". The response options were never-rarely-often-always. The question concerning daytime frequency was "What is the longest interval between each voiding, from when you wake up until you go to bed?" with response options of more than 3 h-2-3 h-1-2 h-less than 1 h. The question concerning nocturia was "How many times do you have to urinate per night?" with response alternatives of none-1 or 2 times-3 or 4 times-5 times or more. The preceding 4-week period was used as the reference time frame for the questions. For the analysis, each symptom was recoded into a binary variable: no or mild vs. moderate or severe symptoms (the first two versus the two latter options). The men were followed up for mortality through the population registry until the end of 2014. Information on the time and cause of death was obtained by a deterministic linkage with the unique personal identification number as the key.
Statistical analyses
For analyses of mortality, we included men who had answered questions for LUTS at every survey in 1994-2009 (while alive) and for comorbidities at least in the 1994 survey. To adjust the analyses for confounders, variables with well-established prognostic importance were selected for regression analyses. These variables, of which many are also known to be associated with LUTS, included age, marital status (married or cohabiting versus single or widowed), body mass index (BMI, ≤25 versus >25 kg/m 2 ), current smoking (yes/no), alcohol consumption (≤150 g/ week vs. >150 g/week), previous diagnosis of diabetes, hypertension, cardiac disease, pulmonary disease, cerebrovascular disease, cancer, and neurological disease.
Univariate Cox regression analysis was performed for each potential prognostic variable. All variables were included in the multivariable analyses to assess their independent effects on each LUTS. All characteristics were treated as time-dependent categorical variables in the regression model. "Last observation carried forward" method [16] was used for comorbidities with missing values in the following rounds. Parallel analyses were made for each LUTS to provide timevarying hazard ratios using variable values updated every 5 years (time-dependent analysis). To further examine the effect of fluctuation of LUTS and associated comorbidities, and for easier comparison to previous studies, sensitivity analyses were conducted using values of all variables fixed to the baseline assessment (1994) and Kaplan-Meier curves were used to graphically represent these associations. Furthermore, interaction terms were evaluated in the regression models of the association of each LUTS with mortality, and subgroup analyses were conducted for the variables with a significant interaction. For all statistical analyses, SPSS version 23 was used.
Results
A total of 2198 questionnaires (70%) were returned in 1994, 2133 (75%) in 1999, 1905 (76%) in 2004, and 1424 (66%) in 2009 of whom 1332 were eligible for the study by providing sufficient data for the analyses, i.e. having answered questions regarding LUTS at every survey (while alive). Regarding the age distribution of the included men, the proportions were 41%, 36 and 23% for men aged 50, 60, and 70 at the baseline, respectively. Men with LUTS were generally older than those without LUTS and virtually all medical conditions were more frequent among men with LUTS (Table 1, Suppl. Table 1 ).
The symptoms showed substantial fluctuation with a decreasing trend for daytime frequency with a prevalence of 10.8% at the baseline and 7.3% at 15 years and an increasing trend for nocturia, with prevalence 3.8% at the baseline and 8.9% at 15 years. Reflecting the modified question in the assessment of urgency in 1994, its prevalence was materially lower at the baseline (1.8%) compared to the subsequent rounds (14.5% at 5, 17.8% at 10, and 19.1% at 15 years) (Fig. 1) . 
Analyses of mortality
During the 21-year follow-up, 514 men died, of whom 139 during the first, 126 during the second and 112 during the third 5-year period and 137 during the last period of 6 years. The overall mortality was 10.4% at 5 years, 19.9% at 10 years, 28.3% at 15 years, and 38.6% at 21 years. Mortality was higher among men with LUTS at every stage of follow-up (Fig. 1) . In unadjusted time-dependent analyses, each of the studied storage symptoms was strongly associated with an increased risk of death: the HR was 1.71 (95% CI 1.36-2.14) for urgency, 1.95 (1.52-2.49) for daytime frequency and 2.31 (1.79-2.98) for nocturia (Table 2 ). In unadjusted analyses with fixed baseline characteristics, daytime frequency and nocturia were significantly associated with an increased risk of death, while urgency showed no significant association: HR 1.43
(1.11-1.84) for daytime frequency, 2.56 (1.81-3.63) for nocturia and 1.52 (0.86-2.69) for urgency (Fig. 2 , Table 2 ). In multivariable-adjusted time-dependent analyses, daytime frequency, and nocturia remained significantly associated with an increased risk of death, while urgency showed only a suggestive association: the adjusted HR was 1.42 (1.11-1.83) for daytime frequency, 1.38 (1.07-1.79) for nocturia and 1.19 (0.94-1.50) for urgency (Table 2, Suppl. Table 2 ). In multivariable-adjusted analyses with fixed baseline characteristics, only nocturia was suggestively associated with an increased risk of death: the adjusted HR was 0.94 (0.52-1.68) for urgency, 1.09 (0.84-1.42) for daytime frequency and 1.41 (0.99-2.02) for nocturia (Table 2, Suppl. Table 3 ).
In the regression analysis, a significant interaction was found between smoking and urgency (p = 0.02), as well as between previously diagnosed cardiac disease and urgency (p Fig. 1 Flow chart of mortality rates of men in relation to baseline prevalences and periodic incidence and remission rates of urinary urgency, frequency and nocturia = 0.04). The effect of urgency was suggestively stronger among non-smokers compared to smokers (HR 1.46, 1.12-1.91 vs. 0.73, 0.45-1.20) and among those without a diagnosed cardiac disease compared to those with a diagnosis (HR 1.30, 0.95-1.79 vs. 1.04, 0.73-1.48) ( Table 3 ). The effects of daytime frequency and nocturia showed no significant differences between any subgroups. (Suppl. Table 4 ).
Discussion
Due to the fluctuating nature of the symptoms and related comorbidities, the impact of LUTS as predictors of mortality has not been well-established. The influence of shortterm fluctuating symptoms can mask the effect of clinically relevant longer-term symptoms, compromising the reliability of the observed association of baseline LUTS on subsequent morbidity. To provide more robust estimates, we explored the impact of LUTS on mortality utilizing repeated assessments of these symptoms and associated comorbidities. Our results showed that men with nocturia or daytime frequency have increased mortality, even after adjustment for behavioral risk factors and comorbidities. However, the associations were significant only in analyses where the symptoms and comorbidities were updated every 5 years indicating that the baseline assessments of LUTS are reliable only in predicting short-term mortality risk while repeated assessments are needed to predict longer term risk.
The crude death rates were higher in men with LUTS throughout the follow-up. After adjusting for age and comorbidities, daytime frequency, and nocturia remained associated with mortality compared with men free of these Impact of lower urinary tract symptoms on mortality: a 21-year follow-up among middle-aged and elderly. . .
symptoms.
Although an association with mortality was more apparent for daytime frequency and nocturia than urgency, there was indication of an association of urinary urgency with an elevated death risk confined to nonsmokers. In men with urinary urgency, and lacking the confounding effect of smoking-a commonly recognized risk factor for several illnesses, such as cardiovascular diseases-the mortality risk was nearly 1.5-fold. Furthermore, we found an indication of urgency being related to increased mortality in men without a history of cardiac disease, which suggests that urgency might deserve attention as a potential indicator of latent heart disease. Our study provides three important improvements to previous reports of longitudinal associations of LUTS with mortality. First, we are not aware of any former study utilizing repeated assessments and thus taking into account the fluctuation and development of symptoms and comorbidities during follow-up. Second, our follow-up is longer than in any previous study on the topic, and covers more than 500 deaths (including >70 deaths among men with each of the LUTS examined). Third, although some previous studies have assessed the impact of nocturia and urgency on mortality [8, 17] , we are not aware of any earlier study assessing mortality in relation to daytime frequency. Our effect size for mortality associated with nocturia is consistent with most previous studies showing, on average, a 1.3-fold risk [8] . Similarly, the magnitude of risk associated with urgency is fairly consistent with a previous Finnish study of elderly men reporting a 1.9-fold mortality at 10-year follow-up [17] .
Regarding the limitations of the study, the nocturia question in DAN-PSS-1 does not distinguish one void from two voids per night. Because one nocturnal voiding is often considered normal, one or two voids/night are unlikely to distinguish meaningful nocturia and thus, ≥3 voids/night was considered a more robust indicator of important nocturia. Accordingly, a previous study suggested a gradient in risk of death with nocturia severity [18] . Furthermore, although incidence of nocturia is independent of nocturia case definition (≥1, ≥2, or ≥3 voids/night), remission frequency increases with more stringent criteria [9] . Due to a more stringent case definition in our analyses, remission over time is more likely and repeated assessments are therefore crucial.
Due to the relatively small number of deaths related to specific symptoms, our study did not have adequate statistical power to analyse the impact of multiple LUTS in combination. However, previous findings suggest that storage symptoms frequently overlap and various LUTS are often concomitant [19] . Furthermore, we were unable to assess the effect of treatments of LUTS on death. However, few men seek treatment for their LUTS [19, 20] and response to treatment can be unsatisfactory particularly for storage symptoms [2, 3, 21] . Finally, some residual confounding in our results is likely in spite of extensive adjustments with various medical conditions and lifestyle factors.
Although urinary symptoms are common in aging men, they may also be markers of ill health. Investigations for underlying comorbidity are warranted particularly in cases of persistent and treatment-resistant symptoms. The multifactorial etiology of LUTS includes various medical conditions and behavioral factors, besides age-related changes in the lower urinary tract such as development of BPH. Although LUTS share common etiologic factors, distinction between specific symptoms is important due to the different pathophysiologic mechanisms, especially in nocturia, which has been recently recognized as a separate clinical entity [22] . The proposed etiologies underlying various LUTS include vascular insufficiency of the pelvic floor due to atherosclerosis [23, 24] , systemic inflammation in metabolic syndrome [25] , neurogenic dysfunction related to diabetes [26] , fluid shifts caused by hypertension and cardiac failure [27] as well as increased sympathetic activity caused by hyperinsulinemia or sleep problems [26, 28] . These complex pathways may explain the association of LUTS with increased mortality. However, the evidence on the usefulness of various LUTS as causal risk factors for mortality is lacking: there is no data available on whether treatment of LUTS would decrease mortality e.g. by preventing injuries or cardiovascular events to occur [6, 7, 29] .
In conclusion, LUTS are more accurate predictors of shortterm than longer-term mortality risk among aging men. Repeated assessments are needed to identify clinically relevant and persistent symptoms, often associated with ill health. Accordingly, middle-aged and elderly men presenting with daytime frequrency or nocturia are potentially at a 1.4-fold increased risk of death. Therefore, the management of men with LUTS should focus not only on treating the symptoms, but also assessing their general health, risk factors and major comorbidities, including pre-clinical conditions. 
